Shopping Cart 0
Cart Subtotal
USD 0

Adcock Ingram Holdings Ltd (AIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Adcock Ingram Holdings Ltd (Adcock Ingram) develops, distributes and markets a wide range of healthcare products. The company's product portfolio includes consumer and over-the-counter (OTC) products; prescription products; and generic medicines. It provides medicines in the areas of cardiovascular, central nervous system, cough, cold and flu, skin care, diabetes, ear, nose and eye preparations, feminine health, pain and respiratory diseases among others. Adcock Ingram also supplies critical care products, including blood collection products, intravenous solutions and renal dialysis systems. It operates three manufacturing facilities, namely, high volume liquids facility, tablet and capsule facility and critical care facility. The company supplies its products to both the private and public sectors of the market. Adcock Ingram is headquartered in Midrand, South Africa.

Adcock Ingram Holdings Ltd (AIP)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 12

Private Equity 13

Actis Rumored To Acquire Adcock Ingram For USD 1.25 Billion 13

Partnerships 14

EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 14

Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 15

Asset Transactions 16

Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 16

Acquisition 17

Adcock Ingram to Acquire Genop 17

Adcock Ingram Acquires Virtual Logistics 18

Dannex Acquires 53.47% Stake in Ayrton Drug from Adcock Ingram Holdings 19

Ascendis Health to Acquire Majority Stake in Scientific Group for USD26 Million 20

Public Investment Acquires Additional 3.17% Stake In Adcock Ingram 21

BB Investment Acquires 32.03% Stake In Adcock Ingram 22

Bidvest And Community Investment Complete Acquisition Of 34.5% Stake In Adcock Ingram For USD 393 Million 23

Bidvest Acquires Additional 2.2% Stake In Adcock Ingram From Oasis 25

Foord Asset Management Acquires Additional 4.81% Stake In Adcock Ingram 26

Public Investment Acquires Additional 3.47% Stake In Adcock Ingram 27

Adcock Ingram Holdings Ltd-Key Competitors 28

Adcock Ingram Holdings Ltd-Key Employees 29

Adcock Ingram Holdings Ltd-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Joint Venture 31

Recent Developments 32

Financial Announcements 32

Aug 29, 2018: The Adcock Ingram reports a positive trading performance 32

Corporate Communications 34

Jan 29, 2018: Adcock Ingram Holdings: Change to the Board of Directors 34

Other Significant Developments 35

Aug 29, 2018: Adcock Ingram Holdings-Group annual results and cash dividend declaration 35

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Adcock Ingram Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 12

Actis Rumored To Acquire Adcock Ingram For USD 1.25 Billion 13

EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 14

Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 15

Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 16

Adcock Ingram to Acquire Genop 17

Adcock Ingram Acquires Virtual Logistics 18

Dannex Acquires 53.47% Stake in Ayrton Drug from Adcock Ingram Holdings 19

Ascendis Health to Acquire Majority Stake in Scientific Group for USD26 Million 20

Public Investment Acquires Additional 3.17% Stake In Adcock Ingram 21

BB Investment Acquires 32.03% Stake In Adcock Ingram 22

Bidvest And Community Investment Complete Acquisition Of 34.5% Stake In Adcock Ingram For USD 393 Million 23

Bidvest Acquires Additional 2.2% Stake In Adcock Ingram From Oasis 25

Foord Asset Management Acquires Additional 4.81% Stake In Adcock Ingram 26

Public Investment Acquires Additional 3.47% Stake In Adcock Ingram 27

Adcock Ingram Holdings Ltd, Key Competitors 28

Adcock Ingram Holdings Ltd, Key Employees 29

Adcock Ingram Holdings Ltd, Subsidiaries 30

Adcock Ingram Holdings Ltd, Joint Venture 31

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Adcock Ingram Holdings Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Adcock Ingram Holdings Ltd (Adcock Ingram) develops, distributes and markets a wide range of healthcare products. The company's product portfolio includes consumer and over-the-counter (OTC) products; prescription products; and generic medicines. It provides medicines in the areas of cardiovascular, central nervous system, cough, cold and flu, skin care, diabetes, ear, nose and eye preparations, feminine health, pain and respiratory diseases among others. Adcock Ingram also supplies critical care products, including blood collection products, intravenous solutions and renal dialysis systems. It operates three manufacturing facilities, namely, high volume liquids facility, tablet and capsule facility and critical care facility. The company supplies its products to both the private and public sectors of the market. Adcock Ingram is headquartered in Midrand, South Africa.

Adcock Ingram Holdings Ltd (AIP)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 12

Private Equity 13

Actis Rumored To Acquire Adcock Ingram For USD 1.25 Billion 13

Partnerships 14

EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 14

Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 15

Asset Transactions 16

Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 16

Acquisition 17

Adcock Ingram to Acquire Genop 17

Adcock Ingram Acquires Virtual Logistics 18

Dannex Acquires 53.47% Stake in Ayrton Drug from Adcock Ingram Holdings 19

Ascendis Health to Acquire Majority Stake in Scientific Group for USD26 Million 20

Public Investment Acquires Additional 3.17% Stake In Adcock Ingram 21

BB Investment Acquires 32.03% Stake In Adcock Ingram 22

Bidvest And Community Investment Complete Acquisition Of 34.5% Stake In Adcock Ingram For USD 393 Million 23

Bidvest Acquires Additional 2.2% Stake In Adcock Ingram From Oasis 25

Foord Asset Management Acquires Additional 4.81% Stake In Adcock Ingram 26

Public Investment Acquires Additional 3.47% Stake In Adcock Ingram 27

Adcock Ingram Holdings Ltd-Key Competitors 28

Adcock Ingram Holdings Ltd-Key Employees 29

Adcock Ingram Holdings Ltd-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Joint Venture 31

Recent Developments 32

Financial Announcements 32

Aug 29, 2018: The Adcock Ingram reports a positive trading performance 32

Corporate Communications 34

Jan 29, 2018: Adcock Ingram Holdings: Change to the Board of Directors 34

Other Significant Developments 35

Aug 29, 2018: Adcock Ingram Holdings-Group annual results and cash dividend declaration 35

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Adcock Ingram Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Adcock Ingram Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Adcock Ingram Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 12

Actis Rumored To Acquire Adcock Ingram For USD 1.25 Billion 13

EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 14

Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 15

Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For USD 85 Million 16

Adcock Ingram to Acquire Genop 17

Adcock Ingram Acquires Virtual Logistics 18

Dannex Acquires 53.47% Stake in Ayrton Drug from Adcock Ingram Holdings 19

Ascendis Health to Acquire Majority Stake in Scientific Group for USD26 Million 20

Public Investment Acquires Additional 3.17% Stake In Adcock Ingram 21

BB Investment Acquires 32.03% Stake In Adcock Ingram 22

Bidvest And Community Investment Complete Acquisition Of 34.5% Stake In Adcock Ingram For USD 393 Million 23

Bidvest Acquires Additional 2.2% Stake In Adcock Ingram From Oasis 25

Foord Asset Management Acquires Additional 4.81% Stake In Adcock Ingram 26

Public Investment Acquires Additional 3.47% Stake In Adcock Ingram 27

Adcock Ingram Holdings Ltd, Key Competitors 28

Adcock Ingram Holdings Ltd, Key Employees 29

Adcock Ingram Holdings Ltd, Subsidiaries 30

Adcock Ingram Holdings Ltd, Joint Venture 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Adcock Ingram Holdings Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

chat_bubbleLet's Chat